J. Aberman

1.0k total citations
10 papers, 871 citations indexed

About

J. Aberman is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Developmental and Educational Psychology. According to data from OpenAlex, J. Aberman has authored 10 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 3 papers in Pharmacology and 3 papers in Developmental and Educational Psychology. Recurrent topics in J. Aberman's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Behavioral and Psychological Studies (3 papers) and Cannabis and Cannabinoid Research (3 papers). J. Aberman is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Behavioral and Psychological Studies (3 papers) and Cannabis and Cannabinoid Research (3 papers). J. Aberman collaborates with scholars based in United States. J. Aberman's co-authors include John D. Salamone, Maria N. Arizzi, Manuel Sandoval, Adrienne J. Betz, A. Makriyannis, Michael S. Cousins, Jonathan D. Sokolowski, Jennifer Trevitt, Keita Ishiwari and Peter McLaughlin and has published in prestigious journals such as Neuroscience, Life Sciences and Psychopharmacology.

In The Last Decade

J. Aberman

10 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Aberman United States 10 673 240 219 203 130 10 871
Patrick A. Randall United States 13 713 1.1× 325 1.4× 186 0.8× 221 1.1× 173 1.3× 19 1.1k
Anna Wisniecki United States 9 473 0.7× 162 0.7× 139 0.6× 162 0.8× 71 0.5× 9 662
David L. Wolgin United States 16 471 0.7× 176 0.7× 82 0.4× 80 0.4× 145 1.1× 50 760
Jonathan D. Sokolowski United States 10 796 1.2× 370 1.5× 58 0.3× 281 1.4× 174 1.3× 10 977
Yasmene B. Shah United Kingdom 9 826 1.2× 509 2.1× 96 0.4× 239 1.2× 97 0.7× 10 1.2k
Kelly S. Sink United States 13 616 0.9× 227 0.9× 417 1.9× 175 0.9× 114 0.9× 14 906
Ralph Esposito United States 15 828 1.2× 283 1.2× 64 0.3× 425 2.1× 105 0.8× 28 1.1k
Amanda L. Sharpe United States 21 772 1.1× 172 0.7× 197 0.9× 340 1.7× 102 0.8× 39 1.1k
C. Spyraki Greece 15 593 0.9× 257 1.1× 80 0.4× 217 1.1× 178 1.4× 23 870
A. G. Phillips Canada 18 778 1.2× 429 1.8× 78 0.4× 307 1.5× 147 1.1× 20 1.1k

Countries citing papers authored by J. Aberman

Since Specialization
Citations

This map shows the geographic impact of J. Aberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Aberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Aberman more than expected).

Fields of papers citing papers by J. Aberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Aberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Aberman. The network helps show where J. Aberman may publish in the future.

Co-authorship network of co-authors of J. Aberman

This figure shows the co-authorship network connecting the top 25 collaborators of J. Aberman. A scholar is included among the top collaborators of J. Aberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Aberman. J. Aberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
McLaughlin, Peter, Anna Wisniecki, J. Aberman, et al.. (2003). The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behavioural Pharmacology. 14(8). 583–588. 141 indexed citations
2.
Arizzi, Maria N., J. Aberman, Adrienne J. Betz, et al.. (2003). Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide. Life Sciences. 74(8). 1001–1011. 20 indexed citations
4.
Aberman, J. & John D. Salamone. (1999). Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement. Neuroscience. 92(2). 545–552. 208 indexed citations
5.
Salamone, John D., J. Aberman, Jonathan D. Sokolowski, & Michael S. Cousins. (1999). Nucleus accumbens dopamine and rate of responding: Neurochemical and behavioral studies. Psychobiology. 27(2). 236–247. 62 indexed citations
6.
Aberman, J., et al.. (1998). A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing. Psychopharmacology. 137(2). 147–156. 38 indexed citations
7.
Trevitt, Jennifer, A. Atherton, J. Aberman, & John D. Salamone. (1998). Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat. Psychopharmacology. 137(1). 61–66. 35 indexed citations
8.
Aberman, J., et al.. (1998). Effects of Dopamine Antagonists and Accumbens Dopamine Depletions on Time-Constrained Progressive-Ratio Performance. Pharmacology Biochemistry and Behavior. 61(4). 341–348. 170 indexed citations
9.
Mayorga, Arthur J., et al.. (1997). Motor Dysfunction Produced by Tacrine Administration in Rats. Pharmacology Biochemistry and Behavior. 58(4). 851–858. 37 indexed citations
10.
Trevitt, Jennifer, et al.. (1997). Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function. Psychopharmacology. 132(1). 74–81. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026